Status:
COMPLETED
Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea
Lead Sponsor:
Papua New Guinea Institute of Medical Research
Collaborating Sponsors:
The University of Western Australia
Conditions:
Pneumonia
Meningitis
Eligibility:
All Genders
1-3 years
Phase:
PHASE2
Brief Summary
The National Health Plan 2001-2010 calls for investigation of the feasibility of pneumococcal vaccines for Papau New Guinea. The Papua New Guinea (PNG) Institute of Medical Research, the Telethon Inst...
Detailed Description
In order to obtain the earliest possible protection against invasive pneumococcal disease, achieve optimal coverage and reduce burden of early carriage, neonatal pneumococcal conjugate vaccine (PCV) i...
Eligibility Criteria
Inclusion
- New born babies with birth weight \>2000 g (2 kgs) and parents giving consent
Exclusion
- Acute neonatal infection;
- Severe congenital abnormality;
- Children of mothers known to be HIV positive will be excluded;
- Serious asphyxia at birth;
- Intended migration in the next 2 years;
- Parents withdraw consent;
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT00219401
Start Date
May 1 2005
End Date
May 1 2010
Last Update
July 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Papua New Guinea Institute of Medical Research
Goroka, EHP, Papua New Guinea, 441